Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Hepatol Res
; 49(3): 264-270, 2019 Mar.
Article
in En
| MEDLINE
| ID: mdl-30171740
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Guideline
Language:
En
Journal:
Hepatol Res
Year:
2019
Document type:
Article
Affiliation country:
Japan
Country of publication:
Netherlands